Abstract
Purpose
(1) To translate original English Cancer Therapy Satisfaction Questionnaire (CTSQ) into Korean and perform validation, (2) to compare CTSQ domains of expectations of therapy (ET), feelings about side effects (FSE), and satisfaction with therapy (SWT) by cancer therapy type.
Methods
Cross-cultural adaptation was performed according to guidelines: translation, back translation, focus-group, and field test. We performed validation with internal consistency by Cronbach’s alpha and construct validity by exploratory factor analysis (EFA) with varimax rotation method. We compared each CTSQ domain between traditional Korean Medicine (TKM) and integrative cancer therapy (ICT) of combining western and TKM by two-sample t test.
Results
Cross-cultural adaptation produced no major modifications in the items and domains. A total of 102 outpatients were participated. Mean age was 51.9 ± 12.4. Most were stage 4 (74.4 %) cancer. Mean scores of ET, FSE, and SWT were 81.2 ± 15.7, 79.5 ± 22.9, and 75.7 ± 14.8, respectively. Cronbach’s alpha of ET, FSE, and SWT were 0.86, 0.78, and 0.74, respectively. EFA loaded items on the three domains, which is very close to that of the original CTSQ. ET and SWT was similar, but FSE was significantly higher in TKM than ICT (87.5 ± 19.3 vs. 74.9 ± 23.5; p = 0.0054).
Conclusions
Cross-cultural adaptation was successful, and the adapted Korean CTSQ demonstrated good internal consistency and construct validity. Similar expectation and satisfaction was shown between the two types of therapy, but patient’s reported feelings about side effects was significantly lower in patients receiving TKM than receiving ICT. Korean version of CTSQ can be used to evaluate Korean cancer patient’s experiences receiving various cancer therapy types.
This is a preview of subscription content, log in via an institution to check access.
References
Trask, P., Tellefsen, C., Espindle, D., et al. (2008). Psychometric validation of the Cancer Therapy Satisfaction Questionnaire. Value in Health, 11(4), 669–679.
Speight, J. (2005). Assessing patient satisfaction: Concepts, applications, and measurement. Value in Health, 8S(1), S6–S8.
Wiggers, J. H., Donovan, K. O., Esdman, S., & Sanson-Fisher, R. W. (1990). Cancer patient satisfaction with care. Cancer, 66, 610–616.
Abetz, L., Coombs, J., Keininger, D., et al. (2005). Development of the Cancer Therapy Satisfaction Questionnaire: Item generation and content validity testing. Value in Health, 8(S1), S41–S53.
Fayers, P., Aaronson, N., Bjordal, K., On behalf of the EORTC Quality of Life Study Group, et al. (1999). EORTC QLQ-C30 scoring manual (2nd ed.). Brussels: EORTC Quality of Life Group.
Atkinson, M. J., Sinha, A., Haas, S. I., et al. (2004). Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Quality of Life Outcomes, 2, 12.
Hatcher, L. (1994). A step-by-step approach to using the SAS ® system for factor analysis and structural equation modeling. Cary, NC: SAS Institute, Inc.
Greene, F. L., Page, D. L., Fleming, I. D., Fritz, A., Balch, C. M., Haller, D. G., et al. (2002). AJCC cancer staging manual (6th ed.). New York, NY, USA: Springer.
Fritz, A., Percy, C., Jack, A., Shanmugarathan, S., Sobin, L., Parkin, D. M., et al. (2000). International classification of diseases for oncology (ICD-O) (3rd ed.). Geneva, Switzerland: World Health Organization.
Fayers, P., & Machin, D. (2001). Quality of life: Assessment, analysis and interpretation. New York, NY, USA: Wiley.
Choi, W. C., Lee, J. H., Lee, E. O., et al. (2006). Study on antiangiogenic and antitumor activities of processed Rhus verniciflua Stokes extract. Korean Journal of Oriental Physiology & Pathology, 20, 1–5.
Choi, W. C., Sminova, Z., Kubasova, I., et al. (2002). Antitumor efficacy of the allergen removed extract in Rhus verniciflua. European Journal of Pharmaceutical Sciences, 17S, S78–S79.
Lee, S. H., Choi, W. C., & Yoon, S. W. (2009). Impact of standardized Rhus verniciflua Stokes extract as complementary therapy on metastatic colorectal cancer: A Korean single-center experience. Integrative Cancer Therapies, 8, 148–152.
Lee, S. H., Kim, K. S., Choi, W. C., & Yoon, S. W. (2009). Successful outcome of advanced pulmonary adenocarcinoma with malignant pleural effusion by the standardized Rhus verniciflua Stokes extract: A case study. Explore, 5, 242–244.
De Vaus, D. (2002). Surveys in social research (5th ed.). Sydney: Allen & Unwin.
Nunnally, J., & Bernstein, I. (1994). The assessment of reliability. Psychometric theory. New York: McGraw-Hill.
Chassany, O., Sagnier, P., & Marquis, P. (2002). Patient-reported outcomes: The example of health-related quality of life—A European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Information Journal, 36, 209–238.
Andresen, E. M. (2000). Criteria for assessing the tools of disability outcomes research. Archives of Physical Medicine and Rehabilitation, 81(12 Suppl 2), S15–S20.
Fitzpatrick, R., Davey, C., Buxton, M. J., & Jones, D. R. (1998). Evaluating patient-based outcome measures for use in clinical trials. Health Technology Assessment, 2(14):i–iv, 1–74.
Portney, L., Watkins, M., et al. (2000). Foundations of clinical research: Applications to practice. Upper Saddle River, NJ: Prentice Hall.
Acknowledgments
This work was supported by a grant from the Kyung Hee University in 2009 (KHU-20081270).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, S.J., An, S.M. & Kim, S.H. Development of a Korean version of the Cancer Therapy Satisfaction Questionnaire (CTSQ): cross-cultural adaptation, reliability, and validity. Qual Life Res 22, 431–436 (2013). https://doi.org/10.1007/s11136-012-0164-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-012-0164-0